Page 68 - 70_01

E. MUÑOZ Y M.ª E. LÓPEZ-OLIVA AN. R. ACAD. NAC. FARM.

(121) THIET, M.P., OSATHANONDH, R., YEH, J. (1994) Localization and timing of
(122) appearance of insulin, insulin-like growth factor I, and their receptors in
(123) the human fetal mullerian tract. Am. J. Obstet. Gynecol. 170: 152-156.
HAN, V.K.M., D´ERCOLE, A.J., LUND, P.K. (1987) Central localization of soma-
(124) tomedin messenger RNA in the human fetus. Science 236: 193-197.
GREEN, B.N., JONES, S.B., STRECK, R.D., WOOD, T.L., ROTWEIN, P., PINTAR, J.E.
(125) (1994) Distinct expression patterns of insulin-like growth factors binding
proteins 2 and 5 during fetal and postnatal development. Endocrinology
(126) 134: 954-962.
(127) ORLOWSKI, C.C., BROWN, A.L., OOI, C.T., YANG, Y.W., TSENG, L.Y., RECHLER,
(128) M.M. (1990) Tissue developmental and metabolic regulation of messenger
(129) ribonucleic and encoding a rat insulin-like growth factor binding protein.
(130) Endocrinology 126: 644-652.
(131) WOOD, T.L., BROWN, A.L., RECHLER, M.M., PINTAR, J.E. (1990) The expression
(132) pattern of an insulin-like growth factor (IGF)-binding protein gene is dis-
(133) tinct from IGF-II in the midgestational rat embryo. Mol. Endocrinology 4:
1257-1263.
(134) CERRO, J.A., GREWAL, A., WOOD, T.L., PINTAR, J.E. (1993) Tissue-specific ex-
(135) pression of the insulin-like growth factor binding protein (IGFBP) mRNAs
in mouse and rat development. Regulatory Peptides 48: 189-198.
ALLAN, G. J., FLINT, D.J., PATEL, K. (2001) Insulin-like growth factor axis
during embryonic development. Reproduction, 122: 31-39.
SPANOS, S., BECKER, D.L., WINSTON R.M., HARDY, K. (2000) Anti-apopto-
tic action of insulin-like growth factor-I during human preimplantation
embryo development. Biol Reprod. 63(5):1413-1420.
WANG, H.S. Y CHARD, T. (1992) The role of insulin-like growth factor-1 and
insulin-like growth factor in the control of human fetal growth. binding
protein-1 in human umbilical cord. J. Endocrinol.132: 11-19.
BAXTER, R.C. (1994) Insulin-like growth factor binding protein in the hu-
man circulation: a review. Hormone Res. 42: 140-144.
LEWITT, M.S., SAUNDERS, H., BAXTER, R.C. (1993) Biovailability of insulin-like
growth factors (IGFs) in rats determined by the molecular distribution of
human IGF-binding protein-3. Endocrinology, 133: 1797-1802.
LEWITT, M.S., SCOTT, F.P., CLARKE, N.M., WU, T., SINOSICH, M.J., BAXTER, R.C.
(1998) Regulation of insulin-like growth factor-binding protein-3 ternary
complex formation in pregnancy. J. Endocrinol. 159: 265-274.
BAXTER, R.C. (1990) Circulating levels and molecular distribution of
the acid-labile (a) subunit of the high molecular weight insulin-like
growth factor binding protein complex. J. Clin. Endocrinol. Metab. 70: 1347-
1353.
FORMBY, B., ULLRICH, A., COUSSENS, L., WALKER, L., PETERSEN, C.M. (1988) GH
stimulates insulin gene expression in cultured human fetal pancreatic is-
lets. J. Clin. Endocrinol. Metab. 66: 1075-1079.
ALMAZAN, G., HONEGGER, P., MATTIEU, J.M., GUENTERT-LAUBER, B. (1985) Epi-
dermal growth factor and bovine GH stimulate differentiation and myeli-
nation of brain cell aggregates in culture. Dev. Brain. Res. 21: 257-264.

70